netbook
desktop
mobile
tablet-landscape
tablet
phone-landscape
phone
Research to Prevent Blindness

Study Links Aging Immune Cells and AMD

RPB-supported researchers at Washington University School of Medicine in St. Louis have published a new study suggesting that aging immune cells increase the risk for age-related macular degeneration (AMD), a major cause of blindness in the United States.

The researchers found that as immune cells called macrophages age, they are more likely to contribute to the inflammation and abnormal blood vessel growth that damage vision in AMD. According to one of the lead researchers on the study, which was published in the scientific journal JCI Insight, the findings could impact future treatment options.

Rajendra S. Apte, MD, PhD, senior investigator on the study. 

“Drug treatments for macular degeneration aren’t effective for some patients, who either have a minimal response or no response at all, and many patients continue to experience vision loss over the long term, even if they have a good initial response to treatment,” said senior investigator Rajendra S. Apte, MD, PhD, the Paul A. Cibis Distinguished Professor of Ophthalmology and Visual Sciences. “But by understanding what happens with the immune cells in the eye, it may be possible to develop therapies to help patients who can’t be helped with existing drugs.”

Read the full news article from WUSMSL

Related News: Feature Story, Macular Degeneration, Top Story

Research to Prevent Blindness Expands Grants Program

Many of the organization’s individual grants will now be open to researchers at any U.S. academic medical center.

Read More

 

Study Tests Stem Cell-based Therapy for Advanced Dry AMD

RPB-supported researchers at the University of Southern California Roski Eye Institute conducted the human trial.

Read More

 

The National Eye Institute Turns 50

RPB celebrates five decades of sight-saving discoveries at NEI.

Read More

 

Vision Funders Collaborate for Impact

RPB hosted its fifth annual convening of organizations that fund vision research in Washington DC.

Read More

 

RPB and AAO Announce New Grant Opportunities to Support Vision Research

Partnership to utilize IRIS Registry database to advance patient care.

Read More

 

Reversing Retinal Degenerative Diseases: We’re One Step Closer

RPB-supported researchers made a critical discovery about the gene mutation that causes many retinal degenerative diseases, opening the door for a new line of research into potential treatments.

Read More

 

Subscribe

Get our email updates filled with the latest news from our researchers about preventing vision loss, treating eye disease and even restoring sight. Unsubscribe at any time. Under our privacy policy, we'll never share your contact information with a third party.